INTRODUCTION
============

*Acinetobacter baumannii*, a ubiquitous and opportunistic Gram-negative pathogen, have shown insusceptibility to a wide range of antimicrobial agents, including β-lactamases, which are frequently used in clinical operations ([@B1]). Based on the molecular structure, beta-lactamases are subcategorized into four major classes, including A, B, C and D. Classes A to C are both chromosomally encoded and plasmid-encoded enzymes ([@B2]). Class D beta-lactamases, known as oxacillinases enzymes or OXA beta-lactamases, are relatively scarce and are identifiable only as plasmid-encoded beta-lactamases. These enzymes have a substrate profile limited to penicillin and oxacillin, though some of them confer resistance to cephalosporins. After considering by Bush et al. ([@B3]), the substrate profile of OXA beta-lactamases were designated as 2d, which OXA-1 to OXA-11 are representative enzymes of this class. Carbapenem-hydrolyzing class D beta-lactamases (CHDLs) are a subgroup of class D beta-lactamases that hydrolyze carbapenem antibiotics and have multidrug-resistant to *A. baumannii.*

An increased number of carbapenem-resistant *A. baumannii* isolates harboring *bla*~OXA-23~, *bla*~OXA-24~ (also named *bla*~OXA-40~), and *bla*~OXA-58~ genes have been reported since the 1980s of the last century ([@B3], [@B4]). It is also found that some intrinsic chromosomally encoded OXA-51-like enzymes can mediate resistance to carbapenems when their gene expression is promoted by the environment or mobile genetic elements ([@B5], [@B6]). OXA-23-like enzymes are pinpointed worldwide and are the most widespread OXA-like enzyme in *A. baumannii* ([@B7]). In Iran, *bla*~OXA-23~, as the most, and *bla*~OXA-24~, as the less, frequent CHDL-encoding genes are far been reported ([@B8], [@B9], [@B10]), and evidence has revealed that the *bla*~OXA-58~ gene distribution in Iran and the neighboring countries is less than other CHDL-encoding genes ([@B9]--[@B15]).

Expression and transformation of the OXA genes could be facilitated by insertion sequences (ISs) such as IS*Aba-1*, IS*Aba-4*, and IS*Aba1-25*, which encode the transposases upstream of *bla*~OXA~ genes and provide an effective promoter for the gene ([@B16]). IS*Aba-1*, from IS4 family, has been found to be the upstream of *bla*~OXA-51~, *bla*~OXA-23~ and *bla*~OXA-58~ genes in *Acinetobacter* species ([@B17], [@B18]). It is well documented that resistance to carbapenems mediated by *bla*~OXA-like~ genes can be regulated by the upstream presence of IS*Aba-1* sequence ([@B12], [@B13], [@B18]). Only a very limited studies in Iran have studied the association of the *bla*~OXA-51~ and *bla*~OXA-23~ genes with IS*Aba-1* ([@B19], [@B20]), and there is no report on the IS*Aba-1* up-regulation of *bla*~OXA-58~ gene.

The emergence of carbapenem resistance mediated by OXA enzymes in *A. baumannii* has demoted the clinical efficacy of this antibiotic, and few studies have unveiled the impact of these enzymes. Hence, the present study was aimed to evaluate the recent antibiotic susceptibility pattern of carbapenem in *A. baumannii* isolates recovered from burn wound infections at a general hospital of Tehran, Iran. This study also verified the presence of *bla*~OXA-23-like~, *bla*~OXA-24-like~ and *bla*~OXA-58-like~ genes and investigated their association with IS*Aba-1*.

MATERIALS AND METHODS
=====================

Bacterial isolates.
-------------------

The study included a total of 84 non-repetitive strains of *A. baumannii* isolated from patients with burn wounds in a general hospital of Tehran from 2016 to 2018. The enrolled population was adult patients, of both male and female genders. All patients had serious wound infections that developed to sepsis, uroinfection or pneumonia. The strains were identified by standard microbiological and biochemical techniques ([@B21]) and by PCR detection of the intrinsic carbapenemase gene *bla*~OXA-51-like~ ([@B22]).

Ethical issues.
---------------

This study was conducted following the approved institutional guidelines of the Islamic Azad Medical University in Tehran (Code: IR.IAU.TMU.REC.1396.279) and volunteer's data were anonymized before analysis.

Antibiotic susceptibility test.
-------------------------------

Minimal inhibitory concentrations (MICs) for 15 antibiotics were determined by the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) ([@B23]) and *Escherichia coli* ATCC 25922 and *Pseudomonas aeruginosa* ATCC 27853 strains were used as references. Initial concentration of antibiotics (AppliChem, Germany) for MIC determination was (256 μg/ml). Antibiotics were selected based on antimicrobial categories proposed by Magiorakos et al. ([@B24]) as follows; gentamicin, amikacin, ceftriaxone, cefepime, ciprofloxacin, levofloxacin, ceftazidime, imipenem, meropenem, ploymyxin B, colistin, ampicillin, tetracycline, tigecycline, aztreoam. In this study MDR (multidrug-resistant) was defined as acquired non-susceptibility to at least one agent in three or more antimicrobial categories, XDR (extensively drug-resistant) was defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial categories (i.e. bacterial isolates remain susceptible to only one or two categories) and PDR (pandrug-resistant) was defined as non-susceptibility to all agents in all antimicrobial categories ([@B24]).

*bla*~OXA-like~ genes detection.
--------------------------------

Genomic DNA was extracted using the DNA isolation kit (MBST, Iran) as recommended by the manufacturer. Detection of the intrinsic carbapenemase encoding gene *bla*~OXA-51-like~ and three other OXA-carbapenemase genes including *bla*~OXA-23-like~, *bla*~OXA-24-like~ and *bla*~OXA-58-like~ was carried out by multiplex PCR using primers listed in [Table 1](#T1){ref-type="table"} ([@B22], [@B25]).

###### 

Sequence of the primers used in this study.

  **Target**                   **Primer**              **Sequence (5′ to 3′)**   **Amplicon Size (bp)**   **Annealing Temperature (ºC)**   **Reference**
  ---------------------------- ----------------------- ------------------------- ------------------------ -------------------------------- ----------------
  *bla*~OXA-51-like~           OXA-51-F                TAATGCTTTGATCGGCCTTG      353                      58                               [@B22]
  OXA-51-R                     TGGATTGCACTTCATCTTGG                                                                                        
  *bla*~OXA-23-like~           OXA-23-F                GATGTGTCATAGTATTCGTCG     1065                     58                               [@B25]
  OXA-23-R                     TCACAACAACTAAAAGCACTG                                                                                       
  *bla*~OXA-24-like~           OXA-24-F                GGTTAGTTGGCCCCCTTAAA      246                      58                               [@B22]
  OXA-24-R                     AGTTGAGCGAAAAGGGGATT                                                                                        
  *bla*~OXA-58-like~           OXA-58-F                AAGTATTGGGGCTTGTGCTG      599                      58                               [@B22]
  OXA-58-R                     CCCCTCTGCGCTCTACATAC                                                                                        
  IS*Aba1- bla*~OXA-51-like~   IS*Aba-1*-F             CACGAATGCAGAAGTTG         1200                     60                               [@B17], [@B22]
  OXA-51-R                     TGGATTGCACTTCATCTTGG                                                                                        
  IS*Aba1- bla*~OXA-23-like~   IS*Aba-1*-F             CACGAATGCAGAAGTTG         1600                     60                               [@B17], [@B25]
  OXA-23-R                     TCACAACAACTAAAAGCACTG                                                                                       
  IS*Aba1- bla*~OXA-58-like~   IS*Aba-1*-F             CACGAATGCAGAAGTTG         1259                     60                               [@B17], [@B22]
  OXA-58-R                     CCCCTCTGCGCTCTACATAC                                                                                        

The PCR reaction (25 μl) contained 3--5 μl of template DNA, 2.5 μl of 10× PCR buffer, 0.75 μl of 50 mM MgCl~2~, 0.5 μl of 10 mM dNTPs, 0.25 μl of 5 U/μl of Taq DNA polymerase, and 25 pmol of each primers. Primers used and annealing temperatures are given in [Table 1](#T1){ref-type="table"}. The PCR carried out in a thermocycler (Techne TC512, England) under the following conditions: initial denaturation at 94°C for 5 min followed by denaturation at 94°C for 1 min, annealing at 58°C for 1 min and extension at 72°C for 1 min (30 cycles), and a final extension at 72°C for 7 min. Identified isolates *A. baumannii* (harboring *bla*~OXA-like~ genes), previously reported by Feizabadi et al. ([@B8]), were used as positive controls for studied genes. The PCR products were analyzed by electrophoresis on 1.5% agarose gel (Sigma- Aldrich, Germany) containing ethidium bromide (0.5 μg/ml).

IS*Aba-1* insertion gene detection.
-----------------------------------

The genetic association between IS*Aba1* sequence and *bla*~OXA-51-like~, *bla*~OXA-23-like~ and *bla*~OXA-58-like~ genes was investigated by PCR mapping using IS*Aba-1* forward ([@B10]) and *bla* genes reverse primers ([@B22], [@B25]) ([Table 1](#T1){ref-type="table"}). The PCR carried out as the *bla*~OXA-like~ multiplex PCR, except that 20 pmol of each primer were used in PCR mixture, and an annealing temperature of 60°C for 45s and extension at 72°C for 3 min was used for 35 cycles of reaction. PCR products were sequenced in the absence of positive controls.

RESULTS
=======

Antibiotic susceptibility.
--------------------------

High percentage of *A. baumannii* isolates were resistant to tetracycline, ciprofloxacin, and levofloxacin, while polymyxin B and colistin were the most effective antibiotics. The results also showed a noticeable resistance rate to cephalosporins and tigecycline. The total antibiotic resistance results are presented in [Fig. 1](#F1){ref-type="fig"}. According to the epidemiological definition, all 84 isolates (100%) were grouped as MDR, whereas 58 isolates (69%) were considered as XDR and none of the isolates were grouped as PDR. Different carbapenems MIC ranges (MIC~50~ and MIC~90~) were observed in the isolates harboring *bla*~OXA-like~ genes. Among them, isolates with the OXA-24-like enzyme showed higher carbapenems MIC ranges ([Table 2](#T2){ref-type="table"}).

![Susceptibility profile in 84 burn wound *A. baumannii* isolates](IJM-11-502-g001){#F1}

###### 

MIC values (μg/ml) for imipenem and meropenem in studied *A. baumannii* isolates harboring *bla*~OXA-like~ genes.

  **Gene**                             **Number**     **MIC~50~**   **MIC~90~**   **MIC range**                    
  ------------------------------------ -------------- ------------- ------------- --------------- ---- ----------- -----------
  *bla*~OXA-23~                        45             0.5           0.5           16              8    0.062--32   0.032--32
  IS*Aba-1* --upstream *bla*~OXA-23~   32 out of 45   4             2             16              8    0.062--32   0.032--32
  *bla*~OXA-24~                        35             1             1             32              16   0.032--32   0.032--16
  *bla*~OXA-58~                        26             1             0.5           16              16   0.062--32   0.032--32
  *bla*~OXA-23~ only                   23             0.5           0.25          2               4    0.062--16   0.032--8
  *bla*~OXA-24~ only                   23             0.5           0.5           32              16   0.032--16   0.032--16

Notes: Breakpoints of IM and MEM, MIC ≤2 μg/mL: sensitive; MIC =4 μg/mL: intermediate; MIC ≥8 μg/mL: resistant (CLSI, 2017).

IM: Imipenem, MEM: Meropenem

Distribution of *bla*~OXA-like~ genes.
--------------------------------------

Multiple PCR reactions by *bla*~OXA-like~ genes specific primers produced DNA fragments of 353, 1065, 246 and 599 bp, from *bla*~OXA-51-like~, *bla*~OXA-23-like~, *bla*~OXA-24-like~ and *bla*~OXA-58-like~ genes respectively ([Fig. 2](#F2){ref-type="fig"}). The prevalence of *bla*~OXA-51-like~, *bla*~OXA-23-like~, *bla*~OXA-24-like~ and *bla*~OXA-58-like~ were 100%, 53.57%, 41.67% and 30.95%, respectively. The co-existence of *bla*~OXA-51~, *bla*~OXA-23~ and *bla*~OXA-24~ was observed in 3.57% (3/84) of isolates.

![Detection of *bla*~OXA-like~ genes from *A. baumannii* isolates by multiplex PCR amplification. Lanes 1 to 7: isolates harboring *bla*~OXA-like~ genes. Lane C-: no chromosomal DNA (negative control). Lane M1: 1-kb DNA ladder (SINACLON, Iran).](IJM-11-502-g002){#F2}

Co-existence of *bla*~OXA-51~, *bla*~OXA-23~, *bla*~OXA-58~ and *bla*~OXA-51~, *bla*~OXA-24~, *bla*~OXA-58~ was seen in 20.23% (17/84) and 10.7% (9/84) of isolates respectively. There was an isolate (1.19%) that carried all four genes. Six isolates from 84 (7.14%) carried only the *bla*~OXA-51~ gene. The distribution of *bla*~OXA~-types among carbapenem-resistant *A. baumannii* isolates is shown in [Table 3](#T3){ref-type="table"}.

###### 

*bla*~OXA-like~ genes and IS*Aba-1* insertion sequence distribution among imipenem and/or meropenem resistant *A. baumannii* isolates (n=28).

  **Isolates[^\*^](#TFN3){ref-type="table-fn"}**   ***bla*~OXA-like~ gene**                  
  ------------------------------------------------ -------------------------- ---- ---- ---- ---------------
  1                                                \+                         −    \+   \+   
  3                                                \+                         −    \+   −    
  4                                                \+                         \+   −    \+   *bla*~OXA-23~
  5                                                \+                         \+   −    −    *bla*~OXA-23~
  6                                                \+                         −    \+   −    
  10                                               \+                         \+   −    −    *bla*~OXA-23~
  14                                               \+                         \+   −    \+   *bla*~OXA-23~
  21                                               \+                         −    \+   −    
  25                                               \+                         \+   −    −    *bla*~OXA-23~
  32                                               \+                         −    \+   −    
  33                                               \+                         −    −    −    *bla*~OXA-51~
  50                                               \+                         \+   −    \+   *bla*~OXA-23~
  53                                               \+                         \+   −    −    *bla*~OXA-23~
  59                                               \+                         \+   −    −    *bla*~OXA-23~
  65                                               \+                         −    \+   \+   
  73                                               \+                         −    \+   −    
  74                                               \+                         −    \+   −    
  75                                               \+                         \+   −    \+   *bla*~OXA-23~
  76                                               \+                         \+   −    −    *bla*~OXA-23~
  78                                               \+                         \+   −    \+   *bla*~OXA-23~
  79                                               \+                         −    −    −    
  85                                               \+                         −    \+   −    
  90                                               \+                         −    \+   −    
  91                                               \+                         −    \+   −    
  92                                               \+                         \+   \+   −    *bla*~OXA-23~
  93                                               \+                         \+   −    −    *bla*~OXA-23~
  97                                               \+                         −    \+   −    
  100                                              \+                         −    −    \+   

Isolate numbering is not under the total number of studied isolates

IS*Aba-1* element association.
------------------------------

Among carbapenem-resistant isolates with only *bla*~OXA-51-like~, 4 isolates yielded a band of 1200 bp in a PCR reaction using IS*Aba-1* forward primer and the *bla*~OXA-51-like~ reverse primer ([Fig. 3](#F3){ref-type="fig"}). Isolates with positive PCR products for *bla*~OXA-23-like~ and *bla*~OXA-58-like~ genes showed a band of 1600 and 1259 bp respectively in PCR reactions using forward primer for IS*Aba-1* and the reverse primers for *bla*~OXA-51-like~ and *bla*~OXA-58-like~ genes ([Fig. 3](#F3){ref-type="fig"}). The IS*Aba-1* element was found upstream *bla*~OXA-23-like~ and *bla*~OXA-58-like~ genes in 32 out of 45 (71.11%) and 4 out of 26 (15.38%) *A. baumannii* isolates respectively. IS*Aba-1* insertion sequence presence among 28 carbapenem-resistant is shown in [Table 3](#T3){ref-type="table"}.

![PCR products obtained using the IS*Aba-1* forward primer (IS*Aba-1*F) and *bla*~OXA-like~ gene reverse primers. (a) Carbapenem-resistant isolates carrying only *bla*~OXA-51-like~ after amplification with the IS*Aba-1*F and OXA-51-R primer pair. Lane 1: no chromosomal DNA (negative control). Lanes 2 and 3: DNA of isolates failed to give a band. Lanes 4--7: DNA of isolates with IS*Aba-1* upstream of *bla*~OXA-51-like~ gene with the 1200-bp PCR product. Lane 8: 1-kb DNA ladder. (b) Lane 1: no chromosomal DNA (negative control). Lanes 2--9: DNA of isolates with IS*Aba-1* upstream *bla*~OXA-23-like~ gene with the 1600-bp PCR product. Lane 10: 1-kb DNA ladder. (c) Lane 1: no chromosomal DNA (negative control). Lanes 2--5: DNA of isolates with IS*Aba-1* upstream of *bla*~OXA-58-like~ gene with the 1259-bp PCR product. Lane 6: 1-kb DNA ladder.](IJM-11-502-g003){#F3}

DISCUSSION
==========

The present study showed a remarkable resistance of *A. baumannii* isolates to the tested antibiotics. The significance of these results becomes greater when using third and fourth-generation antibiotics, such as cephalosporins and carbapenems, for the treatment of *A. baumannii* infections. Almost all the isolates studied here indicated susceptibility to polymyxin B and colistin and similar result to that obtained by several numbers of previous studies conducted in Iran ([@B26], [@B9], [@B27], [@B28]). Our study found the susceptibility of 56 out of 58 XDR *A. baumannii* isolates to polymyxin B, meaning that polymyxin B has ability to re-emerge in medical practice for the treatment of infections caused by MDR and XDR *A. baumannii* strains. In a clinical study, it has been suggested that polymyxin B alone or in combination with other antibiotics can decrease the overall mortality and also can remove bacteria from patients. However, further investigations on the pharmacokinetics, pharmacodynamics, and toxicodynamics of polymyxin B are needed to find the appropriate doses of the drug ([@B29]). Aztreonam, a superior antibiotic to ceftazidime and more stable than carbapenemases ([@B30]), was tested in this study and indicated a high prevalence of resistance. The result is comparable with those of other studies ([@B9], [@B26]) and suggest to eliminate aztreonam from the list of therapeutic solutions for *A. baumannii* infections control.

The carbapenem-resistant isolates in the present work could be attributed to the frequent use of carbapenems, especially after explosive dissemination of ESBLs and CTX-M pandemic. Besides, this behavior may arise from multiple mechanisms of carbapenem resistance in *A. baumannii* and dissemination of carbapenemases by the acquisition of plasmid/chromosome-mediated resistance genes ([@B4]). It is noteworthy to say that, all imipenem- and meropenem-resistant *A. baumannii* strains of this study were identified as MDR and XDR.

To assay OXA beta-lactamases as a carbapenem resistance mechanism, the isolates were screened for the most prevalent *bla*~OXA~ genes, including *bla*~OXA-23-like~, *bla*~OXA-24-like~ and *bla*~OXA-58-like~ ([@B4]). The products of these genes are consistently associated with resistance or at least reduced susceptibility to carbapenems ([@B4]). The isolates were also screened for *bla*~OXA-51-like~, a prevalent and an intrinsic gene in *A. baumannii* species with the chromosomal origin that has a relatively weak ability to hydrolyze carbapenems ([@B4], [@B5]). *bla*~OXA-like~ genes are candidates for IS*Aba-1* acquisition, which is commonly associated with the expression of CHDL-encoding genes in *A. baumannii* and can contribute to carbapenemase genes spread among *Acinetobacter* species ([@B4], [@B16]). To survey this, the association of IS*Aba-1* with *bla*~OXA-51-like~ (in *bla*~OXA-23-like~-, *bla*~OXA-24-like~- and *bla*~OXA-58-like~-negative isolates), *bla*~OXA-23-like~ and *bla*~OXA-58-like~ genes were also investigated in our isolates.

The *bla*~OXA-23-like~ gene distribution frequency among all the studied *A. baumannii* isolates was the most, which coordinates with other studies in different regions of Iran and some neighboring countries ([@B9]--[@B15], [@B19], [@B20], [@B28], [@B31]). There were increased MIC values for imipenem and meropenem in *A. baumannii* isolates harboring *bla*~OXA-23~ gene, especially in ones with upstream IS*Aba-1* element ([Table 2](#T2){ref-type="table"}). Meanwhile, from 13 carbapenem-resistant *A. baumannii* harboring *bla*~OXA-23-like~ all but one showed upstream IS*Aba-1* element, ([Table 3](#T3){ref-type="table"}). These observations emphasize the *bla*~OXA-23-like~ gene role and its up-regulation by IS*A-ba-1* element as a major mechanism for carbapenem resistance phenotype.

OXA-24-like carbapenemase is widely disseminated, but its prevalence is less than OXA-23-like ([@B16]). OXA-24-like frequency among *A. baumannii* isolates has formerly been reported in Iran and some neighboring countries. Having looked at previous studies, we found that over time, *bla*~OXA-24-like~ gene distribution has increased ([@B9]--[@B15], [@B19], [@B20], [@B28], [@B31]). In the present study, the spread of the *bla*~OXA-24-like~ gene (41.66%) was noticeably higher than the rates reported previously ([@B9]--[@B15], [@B19], [@B20], [@B28], [@B31]). A possible explanation for such elevation could be the cephalosporin antibiotics overuse, especially because almost all the *A. baumannii* isolates harboring *bla*~OXA-24-like~ genes were resistant to ceftriaxone, cefepime, and ciprofloxacin. According to the results summarized in [Table 2](#T2){ref-type="table"}, *A. baumannii* isolates harboring the *bla*~OXA-24-like~ gene showed higher MIC values than those with *bla*~OXA-23-like~. This evidence reflects the higher contribution of the *bla*~OXA-24-like~ gene in carbapenem resistance than *bla*~OXA-23-like~, which is in accordance with a recent study ([@B32]).

*bla*~OXA-58-like~ gene was identified in 30.95% of the studied isolates, which was remarkably higher than other reports in Iran ([@B9]--[@B11], [@B20], [@B28]) and neighboring countries ([@B12]--[@B15], [@B31]). Association of IS*Aba-1* gene with the *bla*~OXA-58-like~ in *A. baumannii* isolates of the present study, which was observed for the first time in Iran, is a justification for its growth in dissemination and suggests the possibility of wider dissemination of *bla*~OXA-58-like~ gene.

In this study, from 28 carbapenem-resistant *A. baumannii* isolates, 27 harbored *bla*~OXA-23-like~ and/or *bla*~OXA-24-like~ and/or *bla*~OXA-58-like~ genes which signifies the responsibility of these genes in carbapenem resistance. However, examining the higher number of carbapenem-resistant *A. baumannii* isolates could assist to come to a stronger conclusion regarding the importance of OXA β-lactamases in carbapenem resistance.

In conclusion, the high frequency of MDR and XDR *A. baumannii* strains, in the present study, represents the wide dissemination of antibiotic-resistant *A. baumannii* strains in the healthcare centers of Iran and only polymyxin B, colistin, imipenem, and meropenem can be considered as effective drugs for the treatment of *A. baumannii* infection. This problem can be managed by Iran's annual reports on drug resistance to the World Health Organization (WHO) and Central Asian and Eastern European Surveillance of Antimicrobial Resistance (CAESAR). Our results provided evidence for higher prevalence of *bla*~OXA-24-like~ and *bla*~OXA-58-like~ genes than past and the association of the *bla*~OXA-58-like~ gene with the IS*Aba-1* insertion sequence can speculate a shift in *bla*~OXA-like~ genes distribution in Iran. More studies are required to strengthen the proposed hypothesis. As carbapenems are not as toxic as colistin, it is essential to preserve their efficacy for clinical success against *A. baumannii*. This goal may achieve by accurate monitoring of resistance mechanisms to carbapenems.
